Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases.
Zhang K, Wan P, Wang L, Wang Z, Tan F, Li J, Ma X, Cen J, Yuan X, Liu Y, Sun Z, Cheng X, Liu Y, Liu X, Hu J, Zhong G, Li D, Xia Q, Hui L.
Cell Stem Cell. 2024 Aug 1;31(8):1187-1202.e8. doi: 10.1016/j.stem.2024.04.022. Epub 2024 May 20.
PMID:38772378
An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
Gu P, Xie L, Chen T, Yang Q, Zhang X, Liu R, Guo J, Wei R, Li D, Jiang Y, Chen Y, Gong W, Chen P.
J Hepatol. 2024 Mar;80(3):454-466. doi: 10.1016/j.jhep.2023.10.037. Epub 2023 Nov 10.
PMID:37952766
Hepatorenal tyrosinemia.
Kitagawa T.
Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(5):192-200. doi: 10.2183/pjab.88.192.
PMID:22687740
Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model.
Li Z, Guo R, Sun X, Li G, Shao Z, Huo X, Yang R, Liu X, Cao X, Zhang H, Zhang W, Zhang X, Ma S, Zhang M, Liu Y, Yao Y, Shi J, Yang H, Hu C, Zhou Y, Xu C.
Nat Commun. 2024 Jan 27;15(1):831. doi: 10.1038/s41467-024-45197-z.
PMID:38280857
Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes.
Deng B, Ma Y, Huang J, He R, Luo M, Mao L, Zhang E, Zhao Y, Wang X, Wang Q, Pang M, Mao Y, Yang H, Liu L, Huang P.
Sci Adv. 2024 Jun 7;10(23):eado1550. doi: 10.1126/sciadv.ado1550. Epub 2024 Jun 7.
PMID:38848358
[Richner-Hanhart syndrome].
Zribi H, Souissi A, Azzouz H, Tebib N, Mokni M.
Presse Med. 2016 Feb;45(2):264-5. doi: 10.1016/j.lpm.2015.03.016. Epub 2016 Feb 12.
PMID:26880079
Alkaptonuria - Past, present and future.
Davison AS, Norman BP.
Adv Clin Chem. 2023;114:47-81. doi: 10.1016/bs.acc.2023.02.005. Epub 2023 Mar 28.